Surplus Solutions buys DCM BioServices to expand lab automation service platform

Surplus Solutions has acquired Frederick, Maryland-based DCM BioServices to deepen its technical service capabilities for laboratory automation equipment. The deal adds maintenance, repair, support and integration expertise as Surplus targets growth across biotechnology, pharmaceutical and life sciences markets.

Why it matters: - The deal gives Surplus Solutions a broader technical services offering across the full lifecycle of liquid handling and lab automation equipment. - Preventive maintenance and service contracts can add recurring revenue and strengthen customer retention. - The combined platform is aimed at labs that need faster repairs, less downtime and longer equipment life.

What happened: - Surplus Solutions, a portfolio company of NMS Capital, acquired DCM BioServices on July 1, 2026. - DCM BioServices is based in Frederick, Maryland. - Surplus Solutions said the acquisition expands its technical service capabilities and supports growth in biotechnology, pharmaceutical and life sciences markets. - Terms of the transaction were not disclosed.

The details: - DCM BioServices was founded in 2011. - The company services more than 3,000 instruments across more than 200 labs nationwide. - DCM BioServices focuses on laboratory automation field service. - Its expertise covers platforms from Beckman Coulter, Agilent, Hamilton, Tecan, Thermo Fisher Scientific and others. - The company also provides technical support and full-coverage service agreements. - DCM BioServices serves biotechnology firms, pharmaceutical companies and academic research institutions. - Surplus Solutions was founded in 2006 and is headquartered in Woonsocket, Rhode Island. - Surplus Solutions provides equipment sourcing, resale, refurbishment, relocation, technical repair and maintenance services. - The company operates across the U.S. and Europe. - McDermott Will & Schulte advised Surplus Solutions on legal matters. - TPG Twin Brook Capital Partners provided financing for the transaction. - Drew Murphy Law advised DCM BioServices.

Between the lines: - The acquisition fits NMS Capital’s strategy of building out service businesses with recurring revenue potential. - Surplus Solutions gains specialized lab automation know-how that can complement its existing equipment lifecycle management business. - Dave May, founder and director of service and automation at DCM BioServices, said joining Surplus Solutions should help the team scale its technical service offering. - Joe Reale, CEO of Surplus Solutions, said the acquisition supports a strategy to build a world-class equipment lifecycle management platform. - David Peterson, partner at NMS Capital, said preventive maintenance contracts are a natural extension of Surplus Solutions’ customer relationships.

What's next: - Surplus Solutions and DCM BioServices will operate as a combined platform focused on expanding technical service capabilities. - NMS Capital expects to support the combined team as it scales the service offering across the business. - The company is positioning the acquisition to deepen relationships with life sciences customers and broaden its role in lab equipment management.

The bottom line: - Surplus Solutions is moving beyond equipment lifecycle services into a more recurring, high-touch technical support model for lab automation customers.

More information: Surplus Solutions, DCM BioServices, NMS Capital, Surplus Solutions on LinkedIn, Surplus Solutions on YouTube